Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.925 GBX | -.--% | +10.00% | +10.00% |
May. 09 | Advanced Oncotherapy Delists from London Bourse Amid Financing Deal | MT |
May. 03 | Advanced Oncotherapy financing talks continue, funds delayed | AN |
Financials (USD)
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M |
---|---|---|---|---|---|
Net income 2020 | -25M | Net income 2021 | -29M | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M | Net Debt 2021 | 49.09M | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | 174 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
1 week | +10.00% | ||
Current month | +10.00% | ||
1 month | +10.00% | ||
3 months | +10.00% | ||
6 months | +10.00% | ||
Current year | +10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 14-08-26 | |
Director of Finance/CFO | - | 16-09-30 | |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Cross
BRD | Director/Board Member | 64 | 20-09-28 |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Hans von Celsing
BRD | Director/Board Member | 74 | 17-01-25 |
1st Jan change | Capi. | |
---|---|---|
+10.00% | 12.06M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- AVO Stock